CalciMedica
CALC
31 hedge funds and large institutions have $10.9M invested in CalciMedica in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 6 closing their positions.
85% more capital invested
Capital invested by funds: $5.93M → $10.9M (+$5.02M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 30 → 31 (+1)
1.13% less ownership
Funds ownership: 26.67% → 25.54% (-1.1%)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
CALC Hedge Fund Activity: Q3 2025 in Review
31 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2025, worth a combined $10.9M — up 85% from $5.93M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CALC positions and 6 closed out — a net gain of 1 holder — while 5 added to existing stakes and 10 trimmed.
The largest buyer was Stonehage Fleming Financial Services, opening a new position worth an estimated $154K. The largest seller was Soleus Capital Management, cutting an estimated $288K.
- 31 institutional investors held CalciMedica (CALC) as of Q3 2025, up from 30 in Q2 2025.
- Funds reported $10.9M of CalciMedica stock for Q3 2025, up 85% quarter-over-quarter.
- 7 funds opened new CalciMedica positions in Q3 2025 and 6 closed out, a net change of +1 holder.
- The largest CalciMedica buyer in Q3 2025 was Stonehage Fleming Financial Services, an estimated $154K added.
- The largest CalciMedica seller in Q3 2025 was Soleus Capital Management, an estimated $288K sold.
Based on aggregated 13F filings for Q3 2025.